Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma
- PMID: 23313373
- PMCID: PMC3567270
- DOI: 10.1016/j.ajhg.2012.12.006
Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma
Abstract
The purpose of this study was to determine the deep sequencing and analytic conditions needed to detect fetal subchromosome abnormalities across the genome from a maternal blood sample. Cell-free (cf) DNA was isolated from the plasma of 11 pregnant women carrying fetuses with subchromosomal duplications and deletions, translocations, mosaicism, and trisomy 20 diagnosed by metaphase karyotype. Massively parallel sequencing (MPS) was performed with 25-mer tags at approximately 10(9) tags per sample and mapped to reference human genome assembly hg19. Tags were counted and normalized to fixed genome bin sizes of 1 Mb or 100 kb to detect statistically distinct copy-number changes compared to the reference. All seven cases of microdeletions, duplications, translocations, and the trisomy 20 were detected blindly by MPS, including a microdeletion as small as 300 kb. In two of these cases in which the metaphase karyotype showed additional material of unknown origin, MPS identified both the translocation breakpoint and the chromosomal origin of the additional material. In the four mosaic cases, the subchromosomal abnormality was not demonstrated by MPS. This work shows that in nonmosaic cases, it is possible to obtain a fetal molecular karyotype by MPS of maternal plasma cfDNA that is equivalent to a chromosome microarray and in some cases is better than a metaphase karyotype. This approach combines the advantage of enhanced fetal genomic resolution with the improved safety of a noninvasive maternal blood test.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.Prenat Diagn. 2013 Jun;33(6):602-8. doi: 10.1002/pd.4076. Epub 2013 Apr 2. Prenat Diagn. 2013. PMID: 23553438
-
Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14670-5. doi: 10.1073/pnas.1518151112. Epub 2015 Nov 9. Proc Natl Acad Sci U S A. 2015. PMID: 26554006 Free PMC article.
-
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 23302120 Chinese.
-
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10. Ultrasound Obstet Gynecol. 2014. PMID: 24339153 Review.
-
Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results.Genet Med. 2018 Sep;20(9):910-917. doi: 10.1038/gim.2017.219. Epub 2017 Dec 7. Genet Med. 2018. PMID: 29215645 Free PMC article. Review.
Cited by
-
Limited ability of increased sequencing depth in detecting cases missed by noninvasive prenatal testing: a comparative analysis of 3 clinical cases.Sci Rep. 2024 Jan 27;14(1):2304. doi: 10.1038/s41598-024-52767-0. Sci Rep. 2024. PMID: 38280905 Free PMC article.
-
Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies.Sci Rep. 2022 Nov 17;12(1):19750. doi: 10.1038/s41598-022-24337-9. Sci Rep. 2022. PMID: 36396840 Free PMC article.
-
Maternal Xp22.31 copy-number variations detected in non-invasive prenatal screening effectively guide the prenatal diagnosis of X-linked ichthyosis.Front Genet. 2022 Aug 31;13:934952. doi: 10.3389/fgene.2022.934952. eCollection 2022. Front Genet. 2022. PMID: 36118896 Free PMC article.
-
Genome wide noninvasive prenatal testing detects microduplication of the distal end of chromosome 15 in a fetus: a case report.Mol Cytogenet. 2022 Apr 2;15(1):16. doi: 10.1186/s13039-022-00592-3. Mol Cytogenet. 2022. PMID: 35366924 Free PMC article.
-
Expanding the application of non-invasive prenatal testing in the detection of foetal chromosomal copy number variations.BMC Med Genomics. 2021 Dec 11;14(1):292. doi: 10.1186/s12920-021-01131-6. BMC Med Genomics. 2021. PMID: 34895207 Free PMC article.
References
-
- Miller D.T., Adam M.P., Aradhya S., Biesecker L.G., Brothman A.R., Carter N.P., Church D.M., Crolla J.A., Eichler E.E., Epstein C.J. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 2010;86:749–764. - PMC - PubMed
-
- Vetro A., Bouman K., Hastings R., McMullan D.J., Vermeesch J.R., Miller K., Sikkema-Raddatz B., Ledbetter D.H., Zuffardi O., van Ravenswaaij-Arts C.M. The introduction of arrays in prenatal diagnosis: a special challenge. Hum. Mutat. 2012;33:923–929. - PubMed
-
- Novelli A., Grati F.R., Ballarati L., Bernardini L., Bizzoco D., Camurri L., Casalone R., Cardarelli L., Cavalli P., Ciccone R. Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet. Gynecol. 2012;39:384–388. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
